Arcutis to Report Third Quarter 2026 Financial Results and Host Conference Call on November 4, 2026
Key Highlights
- ➤Arcutis (ARQT) will report third-quarter 2026 financial results November 4, 2026.
- ➤Conference call and webcast scheduled for 4:30 p.m. ET after market close.
- ➤Arcutis has approved targeted topicals for three major inflammatory skin diseases.
WESTLAKE VILLAGE, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that it will report its third quarter 2026 financial results and provide a business update after the U.S. financial markets close on Wednesday, November 4, 2026. The Company will host a conference call and webcast at 4:30 p.m. ET that same day.
A live webcast of the call and related presentation materials will be available on the “Events” section of the Company’s website. A replay of the webcast will be available on the Arcutis investor website following the conference call.
Get started
Create a free account to read the full story.